AFIAS HbA1c Neo - India CDSCO Medical Device Registration

AFIAS HbA1c Neo is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000365_ac63ddb8ed54f6df85533efac5147b46_c8ae8b80ab4146fa191763985fe3f2b0. This device is marketed under the brand name AFIAS Infliximab . The license holder is BODITECH MED INDIA PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class B

AFIAS HbA1c Neo

UID: IMP/IVD/2021/000365_ac63ddb8ed54f6df85533efac5147b46_c8ae8b80ab4146fa191763985fe3f2b0

Brand Name

AFIAS Infliximab

License Holder

BODITECH MED INDIA PRIVATE LIMITED

Device Class

Class B

Approving Authority

CDSCO

Product Information

AFIAS HbA1c Neo is a fluorescence immunoassay (AFIAS Infliximab ) for the quantitative determination of HbA1c (AFIAS Infliximab ) in human whole blood. It is useful as an aid in management and monitoring of the long-term glycemic status in patients with diabetes mellitus. For in vitro diagnostic use only

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

TSH

Brand: AFIAS Infliximab

BODITECH MED INDIA PRIVATE LIMITED

AFIAS HbA1c Neo - India CDSCO Medical Device Registration

Brand Name

License Holder

Device Class

Approving Authority

Product Information

DJ Fang

TSH

Progesterone

Myoglobin

AMH

Testosterone

IL-6

AFIAS Total Anti-Infliximab

Ferritin

AFIAS Anti-CCP Plus

FSH

TSH

Progesterone

AFIAS-6

Myoglobin

AMH

Testosterone

IL-6

Cardiac Triple

AFIAS Total Anti-Infliximab

AFIAS NORO